Meeting
2011 ASCO Annual Meeting
Endostar in combination with radiotherapy and paclitaxel/carboplatin in patients with unresectable non-small cell lung cancer of stage III: Preliminary results of a phase II study.
Authors
S. Ma
Hangzhou Cancer Hospital, Hangzhou, China
S. Ma , Y. Xu , X. Sun , Y. Ji , Y. Zheng , S. Wang , J. Chen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Local-regional and Adjuvant Therapy/Small Cell
Track
Lung Cancer
Sub Track
Local-Regional Therapy
Clinical Trial Registration Number
NCT01158144
Citation
J Clin Oncol 29: 2011 (suppl; abstr 7043)
Abstract #
7043
Poster Bd #
21G
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Phase II study of low-dose paclitaxel with timed thoracic radiotherapy (TTR) followed by gemcitabine and carboplatin consolidation in patients with unresectable stage III non-small cell lung cancer (NSCLC): NCT 00449657.
First Author: J. Zhang
Poster
2019 ASCO Annual Meeting
Phase 2 trial of first-line pembrolizumab with platinum doublet chemotherapy and radiotherapy in patients (pts) with unresectable, locally advanced stage III non–small-cell lung cancer (NSCLC): KEYNOTE-799.
First Author: Salma K. Jabbour
Poster
2015 ASCO Annual Meeting
Phase I study of bi-weekly nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer.
First Author: Yukihiro Hasegawa
Poster
2013 ASCO Annual Meeting
Concurrent chemoradiation (CChRT) with bi-weekly docetaxel and cisplatin and thoracic radiotherapy for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician Lung Cancer Group.
First Author: Joaquin Casal Rubio